356P Adjuvant chemotherapy with or without anthracyclines in hormone receptor-positive, HER2-negative early breast cancer with intermediate to high genomic risk
Year: 2025
Type: article
Source: Annals of Oncology
Authors: M. Suh, J.H. Jeong, S.B. Lee, Y. Shin, H. Jeong, J-H. Ahn, K.H. Jung, B-K. Jeong, H.J. Lee, G. Gong, I.Y. Chung, H.J. Kim, B.S. Ko, J.W. Lee, B.H. Son, S-B. Kim
Institutions: Asan Medical Center, University of Ulsan
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Funder: Natera
OpenAlex ID: W4415942607
FWCI:
Cites:
Cited by:
Related to: